BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $867,508 | +6.3% | 19,041 | -5.3% | 0.01% | 0.0% |
| Q1 2023 | $815,864 | -14.7% | 20,115 | +7.2% | 0.01% | -18.8% |
| Q4 2022 | $956,299 | -11.7% | 18,762 | -6.7% | 0.02% | -23.8% |
| Q3 2022 | $1,083,000 | -25.9% | 20,106 | -11.6% | 0.02% | -19.2% |
| Q2 2022 | $1,461,000 | -23.1% | 22,754 | -7.2% | 0.03% | -10.3% |
| Q1 2022 | $1,901,000 | -9.1% | 24,514 | +0.6% | 0.03% | -6.5% |
| Q4 2021 | $2,091,000 | +7.6% | 24,362 | +0.8% | 0.03% | 0.0% |
| Q3 2021 | $1,943,000 | +7.1% | 24,158 | +7.2% | 0.03% | +6.9% |
| Q2 2021 | $1,814,000 | -3.3% | 22,528 | +1.3% | 0.03% | -9.4% |
| Q1 2021 | $1,875,000 | +5.9% | 22,231 | +0.7% | 0.03% | -3.0% |
| Q4 2020 | $1,771,000 | -8.3% | 22,073 | -8.1% | 0.03% | -15.4% |
| Q3 2020 | $1,932,000 | -3.8% | 24,020 | +3.0% | 0.04% | -9.3% |
| Q2 2020 | $2,009,000 | +0.5% | 23,328 | -5.2% | 0.04% | -10.4% |
| Q1 2020 | $1,999,000 | -4.1% | 24,620 | -1.2% | 0.05% | +26.3% |
| Q4 2019 | $2,084,000 | -8.0% | 24,922 | -3.8% | 0.04% | -13.6% |
| Q3 2019 | $2,265,000 | +7.7% | 25,894 | +0.8% | 0.04% | +4.8% |
| Q2 2019 | $2,103,000 | -1.9% | 25,678 | -2.6% | 0.04% | -2.3% |
| Q1 2019 | $2,143,000 | +24.8% | 26,358 | +1.0% | 0.04% | +10.3% |
| Q4 2018 | $1,717,000 | -14.7% | 26,085 | -0.1% | 0.04% | -2.5% |
| Q3 2018 | $2,013,000 | +5.3% | 26,113 | +0.9% | 0.04% | 0.0% |
| Q2 2018 | $1,911,000 | +12.3% | 25,884 | -1.1% | 0.04% | +8.1% |
| Q1 2018 | $1,702,000 | -0.2% | 26,170 | -0.8% | 0.04% | +8.8% |
| Q4 2017 | $1,705,000 | -7.8% | 26,383 | -10.5% | 0.03% | -12.8% |
| Q3 2017 | $1,850,000 | -2.8% | 29,475 | -6.3% | 0.04% | -9.3% |
| Q2 2017 | $1,904,000 | +13.6% | 31,458 | -2.6% | 0.04% | +7.5% |
| Q1 2017 | $1,676,000 | +13.9% | 32,313 | -2.7% | 0.04% | +11.1% |
| Q4 2016 | $1,472,000 | +3.7% | 33,199 | +11.4% | 0.04% | 0.0% |
| Q3 2016 | $1,419,000 | +8.9% | 29,809 | +3.5% | 0.04% | +9.1% |
| Q2 2016 | $1,303,000 | +10.3% | 28,808 | +0.2% | 0.03% | +6.5% |
| Q1 2016 | $1,181,000 | +16.0% | 28,745 | +7.7% | 0.03% | +10.7% |
| Q4 2015 | $1,018,000 | +9.7% | 26,689 | -5.6% | 0.03% | +3.7% |
| Q3 2015 | $928,000 | -51.9% | 28,261 | +2.5% | 0.03% | -48.1% |
| Q2 2015 | $1,929,000 | -26.6% | 27,582 | -28.1% | 0.05% | -5.5% |
| Q1 2015 | $2,628,000 | -3.9% | 38,358 | +2.8% | 0.06% | -3.5% |
| Q4 2014 | $2,736,000 | -2.8% | 37,330 | -4.8% | 0.06% | -5.0% |
| Q3 2014 | $2,816,000 | +5.7% | 39,230 | +6.5% | 0.06% | +7.1% |
| Q2 2014 | $2,664,000 | -0.7% | 36,849 | +1.1% | 0.06% | -3.4% |
| Q1 2014 | $2,683,000 | +10.1% | 36,457 | +4.0% | 0.06% | +9.4% |
| Q4 2013 | $2,437,000 | -3.2% | 35,038 | -8.6% | 0.05% | -10.2% |
| Q3 2013 | $2,518,000 | -2.4% | 38,324 | +2.9% | 0.06% | -4.8% |
| Q2 2013 | $2,580,000 | -11.9% | 37,246 | -7.7% | 0.06% | -15.1% |
| Q1 2013 | $2,930,000 | +8.3% | 40,333 | -0.6% | 0.07% | -5.2% |
| Q4 2012 | $2,705,000 | – | 40,572 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |